Estimates Revisions Forte Biosciences, Inc.
Stocks
FBRX
US34962G2084
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.85 USD | +1.48% |
|
+2.59% | -34.54% |
| 06-03 | Forte Biosciences Files $500 Million Mixed Shelf | MT |
| 05-11 | Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- FBRX Stock
- Consensus Forte Biosciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
